Filter posts

FDA Discusses Effective Patient Engagement at #BIOSummit19

For the FDA, engagement with patients, caregivers and patient advocacy organizations is a vital part …

BIO's Leadership Transition | "The fight continues..."

On Tuesday, October 8, BIO formally announced that its President and CEO Jim Greenwood would …

Discrimination Against Vulnerable Patients Is Nothing New

Transformative therapies are advancing like never before, and a new class of medicines are changing …

Technology to Fight Malaria, Zika, and Other Mosquito-Related Diseases Is Being Blocked. Why?

Every year, mosquitos infect 500 million people with diseases and mosquito-borne illnesses claim nearly a …

#BIOWC19 Day 3 Wrap-Up: Bringing People, Ideas, and Technology Together

Day three of the 2019 BIO World Congress began by awarding three individuals who have had …

New BIO White Paper: Incorporating Real-World Evidence Within the Label of an FDA-Approved Drug

In today’s increasingly connected world, health care researchers have access to previously unimaginable troves of …

Executive Order on Agricultural Biotechnology Is an Important Step Forward

During his June 11th visit to Iowa, President Donald Trump pledged to boost the ethanol …

Opioids: Changing the Paradigm of Treating Pain and Addiction—One Year Later

Drug overdose deaths, including those involving opioids, reached 42,000 in 2016 (CDC), prompting a national …

New Guide to Help Consumers Navigate Genetic Health Testing

In recent years, we have seen a growing array of direct-to-consumer (DTC) genetic testing products …

FDA Approval of GE Salmon Paves Way for Sustainable Food Innovations

Earlier this week, the U.S. Food & Drug Administration (FDA) finally approved the sale of …